ZeroStack has agreed to sell its entire ownership of Phatebo GmbH, a German pharmaceutical wholesaler, to Dutch company New Horizon Pharma B.V. for €2.15 million. The sale would end ZeroStack’s ownership of the German business, but it has not yet closed.
- What is being sold: ZeroStack is selling all of Phatebo’s issued shares, representing its 100% stake. Phatebo is based in Hilzingen, Germany, holds a wholesale medicines license and operates a wholesale business.
- Price: The agreed aggregate purchase price is €2.15 million. The announcement does not specify how the price will be paid.
- Buyer: New Horizon Pharma B.V., based in Amsterdam, is acquiring Phatebo.
- Closing conditions: Completion depends on receiving applicable foreign-investment clearance in Germany and satisfying other conditions in the purchase agreement. No closing date was provided.
If completed, the transaction will remove Phatebo from ZeroStack’s wholly owned businesses. The announcement does not state how ZeroStack intends to use the sale proceeds or provide financial details about Phatebo.